Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Evercore ISI lifts CVS Health stock target to $65, keeps Outperform
Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while maintaining an Outperform rating. The adjustment comes in anticipation of future performance dynamics,
Should You Buy CVS Health Stock Before Feb. 12?
CVS Health (NYSE: CVS) is a big name in healthcare, and it has generally been seen as a good way to invest in the industry. In addition to its pharmacy retail operations, the company has a pharmacy benefits management business.
Is Most-Watched Stock CVS Health Corporation (CVS) Worth Betting on Now?
CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares of this drugstore chain and pharmacy benefits manager have returned +27.
Modern Healthcare
18h
Cigna tumbles after medical costs hit quarterly profit
Cigna Group shares fell sharply after the health insurer reported fourth-quarter profit that was dragged down by medical costs, a trend that’s concerned investors in the sector for months.
14d
UnitedHealth Group CEO says complex US healthcare system needs to change
UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector.
Newsweek on MSN
13d
UnitedHealth CEO Defends Company Amid Price Gouging Accusations
Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's ...
News Nation on MSN
13d
UnitedHealth marked up lifesaving drugs as much as 1,000%: FTC
Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
14d
on MSN
Baltimore City school system sues drug companies over allegedly inflated price of insulin
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
Modern Healthcare
3d
Exchange plans denied nearly 1 in 5 in-network claims in 2023
The share of in-network federal health insurance exchange plan claims denied in 2023 was the highest since 2015, according to ...
3d
on MSN
UnitedHealth Group, two Blues plans had highest denial rates for ACA health plans in 2023
Eden Prairie-based health care giant blasts finding based on just Affordable Care Act plans; researchers note limitations ...
2d
Wells Fargo Remains a Buy on UnitedHealth (UNH)
In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price ...
13d
The FTC Finds United Health’s OptumRX Is Engaged In Widespread Price Gouging
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
Benefits Pro
14d
UnitedHealth's PBM will pass 100% of rebates on to clients: Will more big PBMs follow?
Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback